Title Page
국문초록
Contents
I. Introduction 8
II. Materials and Methods 9
III. Results 12
IV. Discussion 14
References 21
Abstract 25
Table 1. Demographic data of patients with SLE(n=50) 17
Table 2. Distributions of lupus anticoagulant, anti-cardiolipin antibodies and anti-beta2-glycoprotein I antibodies in patients with SLE 18
Table 3. Prevalence of lupus anticoagulant, anti-cardiolipin antibodies and anti-beta2-glycoprotein I antibodies in patients with SLE(percentage of total, n=50) 19
Table 4. Association of individual antiphospholipid tests with clinical features of APS 20